Methotrexate Sodium

CAS 15475-77-1 8 FDA-DMF suppliersSmall Molecule

Overview

Methotrexate sodium is a folate analog metabolic inhibitor that exerts its antineoplastic and immunosuppressive properties by inhibiting the enzyme dihydrofolate reductase, interfering with DNA synthesis, repair, and cellular replication. It is used in the treatment of various types of cancer and autoimmune diseases such as rheumatoid arthritis.

API suppliers (3)

Suppliers of Methotrexate Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • EXCELLA GMBH AND CO KG1 active DMF
  • EXCELLA GMBH AND CO KG1 active DMF
  • LACHEMA BRNO

Therapeutic areas

OncologyRheumatologyDermatology

Related APIs

Apremilast
22 suppliers
Cyclophosphamide
18 suppliers
Imiquimod
15 suppliers
Hydroxychloroquine Sulfate
12 suppliers
Tretinoin
9 suppliers
Fluorouracil
9 suppliers
Baricitinib
8 suppliers
Bleomycin Sulfate
6 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo